PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Maxine Mesinger Multiple Sclerosis Comprehensive Care Center, Baylor College of Medicine, Houston, TX, United States. Electronic address: Carlos.Perez@bcm.edu.\', \'Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX, United States.\', \'Division of Multiple Sclerosis ad Neuroimmunology, Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2211-0348(21)00484-310.1016/j.msard.2021.103217
?:doi
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 34418735
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 severity and outcome in multiple sclerosis: Results of a national, registry-based, matched cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all